Founder of Deciphera Pharmaceuticals, Inc. and Deciphera Pharmaceuticals LLC, Daniel L. Flynn currently occupies the position of Chief Scientific Officer for Deciphera Pharmaceuticals, Inc. and Director & Chief Scientific Officer at Deciphera Pharmaceuticals LLC (a subsidiary of Deciphera Pharmaceuticals, Inc.).

He is also on the board of University of Kansas Center for Research, Inc. and Professor at the University of Kansas.

In his past career Daniel L. Flynn occupied the position of Director-Medicinal Chemistry at Amgen, Inc., Principal at Warner-Lambert Co., Senior Director-Chemistry at Takeda Oncology Co., Director-Medicinal Chemistry at Monsanto Co., Principal at G.D. Searle & Co., Inc., Principal at Parke-Davis Pharmaceutical Research, Inc. and Chairman-Medicinal Chemistry Division at American Chemical Society.

He received a doctorate from the University of Kansas.